candesartan has been researched along with Paralysis, Legs in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Baclofen per se has the potential of lowering blood pressure." | 1.35 | Intrathecal baclofen for autonomic instability due to spinal cord injury. ( Kofler, M; Poustka, K; Saltuari, L, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kofler, M | 1 |
| Poustka, K | 1 |
| Saltuari, L | 1 |
1 other study available for candesartan and Paralysis, Legs
| Article | Year |
|---|---|
Intrathecal baclofen for autonomic instability due to spinal cord injury.
Topics: Abdominal Wall; Antihypertensive Agents; Autonomic Dysreflexia; Baclofen; Benzimidazoles; Biphenyl C | 2009 |